Skip to main content

PerkinElmer Life and Analytical Sciences Revenue Up 6 Percent in Q1

NEW YORK, April 28 (GenomeWeb News) - PerkinElmer yesterday reported a 6-percent rise in first-quarter 2005 revenue from its Life and Analytical Sciences unit, and revenue growth for the quarter of 6 percent for the company overall.

 

PerkinElmer Life and Analytical Sciences revenues for the first three months of 2005 increased to $264.8 million from $249.2 million year over year. The company attributed the growth to "strong growth in genetic screening, medical imaging, environmental and service."

 

The unit's other businesses include "biopharma" and "biotech imaging."

 

The company's overall revenues for the quarter were $416.3 million, up $23.6 million from first-quarter 2004 revenues of $392.6 million.

 

Net income in the first quarter rose from $13.2 million, or $.15 per share, in 2004 to $19.8 million, or $.10 per share, in 2005.

 

R&D spending in the period grew to $23.6 million from $20.2 million in the similar quarter of 2004.

 

As of April 3, the company reported cash and cash equivalents of $184.2 million, with total current assets of $743.2 million.

The Scan

Response Too Slow, Cautious

A new report criticizes the global response to the threat of the COVID-19 pandemic, Nature News reports.

Pushed a Bit Later

Novavax has pushed back its timeline for filing for authorization for its SARS-CoV-2 vaccine, according to Bloomberg.

AMA Announces Anti-Racism Effort

The Associated Press reports that the American Medical Association has released a plan to address systemic racism in healthcare.

Nucleic Acids Research Papers on miRMaster 2.0, MutationTaster2021, LipidSuite

In Nucleic Acids Research this week: tool to examine small non-coding RNAs, approach to predict ramifications of DNA variants, and more.